Nano-X Imaging (NASDAQ:NNOX) Earns Buy Rating from D. Boral Capital

Nano-X Imaging (NASDAQ:NNOX)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research report issued on Monday,Benzinga reports. They currently have a $5.00 price objective on the stock. D. Boral Capital’s price objective would indicate a potential upside of 109.64% from the company’s previous close.

Other research analysts have also issued research reports about the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday. Cantor Fitzgerald upgraded Nano-X Imaging to a “strong-buy” rating in a report on Wednesday, March 4th. Three investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Nano-X Imaging has an average rating of “Buy” and an average price target of $5.00.

Nano-X Imaging Stock Up 5.1%

NASDAQ:NNOX traded up $0.12 on Monday, hitting $2.39. The stock had a trading volume of 497,227 shares, compared to its average volume of 967,452. The business’s fifty day moving average is $2.42 and its 200 day moving average is $3.10. The company has a market cap of $155.93 million, a PE ratio of -1.81 and a beta of 1.39. Nano-X Imaging has a 52 week low of $2.11 and a 52 week high of $5.86.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Engineers Gate Manager LP lifted its holdings in shares of Nano-X Imaging by 272.2% in the fourth quarter. Engineers Gate Manager LP now owns 52,844 shares of the company’s stock valued at $148,000 after purchasing an additional 38,648 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Nano-X Imaging by 20.5% during the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock worth $116,000 after acquiring an additional 3,818 shares during the period. BNP Paribas Financial Markets lifted its holdings in Nano-X Imaging by 64.6% during the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after acquiring an additional 7,749 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Nano-X Imaging by 529.9% during the second quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock worth $71,000 after acquiring an additional 11,604 shares during the period. Finally, Russell Investments Group Ltd. lifted its holdings in Nano-X Imaging by 49.0% during the fourth quarter. Russell Investments Group Ltd. now owns 20,541 shares of the company’s stock worth $58,000 after acquiring an additional 6,754 shares during the period. Institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.